MTInov, an industrial integrator, has obtained the renewal of its labeling for 5 years in the framework of the call for projects “Biotherapy-Bioproduction Integrators” – (IBB) of the National Research Agency (ANR). This labelling was financed within the framework of the National Acceleration Strategy “Biotherapies and Bioproduction of innovative therapies” of the France 2030 Programme.